Moving away from proprietary languages, Roche has made a notable decision to freeze their legacy macros library. With great enthusiasm, they now embrace R as the primary framework for evidence generation in late-stage clinical trials, and they remain open to exploring additional open-source languages in this evolving landscape. James Black, …
Continue reading: <a href=“https://www.r-bloggers.com/2023/09/insig …